Waverley Pharma (TSE:WAVE)
TSXV:WAVE
Holding TSE:WAVE?
Track your performance easily

Waverley Pharma (WAVE) Financial Statements

2 Followers

Waverley Pharma Financial Overview

Waverley Pharma's market cap is currently ―. The company's EPS TTM is C$-0.039; its P/E ratio is -0.70; Waverley Pharma is scheduled to report earnings on August 23, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-C$ 48.73KC$ 96.09KC$ 148.59KC$ 118.69K
Gross Profit-C$ -48.82KC$ 24.64KC$ 102.16KC$ 1.82K
EBITC$ -231.69KC$ -1.30MC$ -289.51KC$ -225.58KC$ -327.84K
EBITDAC$ -205.59KC$ -1.20MC$ -182.94KC$ -119.01K-
Net Income Common StockholdersC$ -264.13KC$ -1.33MC$ -309.96KC$ -240.96KC$ -339.56K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 54.11KC$ 53.02KC$ 31.56KC$ 47.85KC$ 135.12K
Total AssetsC$ 838.45KC$ 952.29KC$ 2.04MC$ 2.21MC$ 2.50M
Total DebtC$ 1.72MC$ 1.60MC$ 1.14MC$ 886.56KC$ 786.86K
Net DebtC$ 1.66MC$ 1.55MC$ 1.11MC$ 838.72KC$ 651.74K
Total LiabilitiesC$ 2.24MC$ 2.09MC$ 1.85MC$ 1.71MC$ 1.75M
Stockholders EquityC$ -1.40MC$ -1.14MC$ 192.30KC$ 502.26KC$ 747.19K
Cash Flow-
Free Cash FlowC$ -112.15KC$ -482.41KC$ -267.92KC$ -186.97KC$ -83.81K
Operating Cash FlowC$ -112.15KC$ -482.41KC$ -267.92KC$ -186.97KC$ -83.81K
Investing Cash Flow-----
Financing Cash FlowC$ 113.24KC$ 503.87KC$ 251.63KC$ 99.70KC$ 85.13K
Currency in CAD

Waverley Pharma Earnings and Revenue History

Waverley Pharma Debt to Assets

Waverley Pharma Cash Flow

Waverley Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis